Study of ALXN1820 in Healthy Adult Participants
Clinical trial NCT04631562 · COMPLETED
Trial details
- NCT number
- NCT04631562
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2022-09-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.